Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Cillo C, Cantile M, Faiella A, Boncinelli E . Homeobox genes in normal and malignant cells. J Cell Physiol 2001; 188: 161–169.

    Article  CAS  Google Scholar 

  2. Abramovich C, Humphries RK . Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 2005; 12: 210–216.

    Article  CAS  Google Scholar 

  3. Strathdee G, Brown R . Aberrant DNA methylation in cancer: potential clinical interventions. Exp Rev Mol Med 2002.

  4. Esteller M . Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 2003; 109: 80–88.

    Article  CAS  Google Scholar 

  5. Herman JG, Baylin SB . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–2054.

    Article  CAS  Google Scholar 

  6. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994; 91: 12223–12227.

    Article  CAS  Google Scholar 

  7. Lawrence HJ, Fischbach NA, Largman C . HOX genes: not just myeloid oncogenes any more. Leukemia 2005; 19: 1328–1330.

    Article  CAS  Google Scholar 

  8. Toiyama Y, Mizoguchi A, Kimura K, Araki T, Yoshiyama S, Sakaguchi K et al. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma. World J Gastroenterol 2005; 11: 5151–5155.

    Article  CAS  Google Scholar 

  9. Doerksen LF, Bhattacharya A, Kannan P, Pratt D, Tainsky MA . Functional interaction between a RARE and an AP-2 binding site in the regulation of the human HOX A4 gene promoter. Nucleic Acid Res 1996; 24: 2849–2856.

    Article  CAS  Google Scholar 

  10. Bijl J, Thompson A, Ramirez-Solis R, Krosl J, Grier DG, Lawrence HJ et al. Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood, 8 December 2005 [E-pub ahead of print].

  11. Crooks GM, Fuller J, Petersen D, Izadi P, Malik P, Pattengale PK et al. Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 1999; 94: 519–528.

    CAS  PubMed  Google Scholar 

  12. Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 2005; 106: 3988–3994.

    Article  CAS  Google Scholar 

  13. So CW, Karsunky H, Wong P, Weissman IL, Cleary ML . Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood 2004; 103: 3192–3199.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Cancer Research UK (GS, AS, RB) and by the Leukaemia Research Fund (AP, DO).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Strathdee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strathdee, G., Sim, A., Parker, A. et al. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 20, 1326–1329 (2006). https://doi.org/10.1038/sj.leu.2404254

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404254

This article is cited by

Search

Quick links